+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Toluidine blue staining of the esophagus. A useful adjunct in the panendoscopic evaluation of patients with squamous cell carcinoma of the head and neck



Toluidine blue staining of the esophagus. A useful adjunct in the panendoscopic evaluation of patients with squamous cell carcinoma of the head and neck



Archives of Otolaryngology--Head & Neck Surgery 113(8): 864-865



Carcinoma of the esophagus has a much higher incidence among patients with squamous cell carcinoma of the head and neck than among the population at large. Esophageal cancer has a low cure rate, and the possibility for increased survival can be enhanced primarily through early detection. Toluidine blue has proved to be effective in demonstrating early malignant lesions that would not be detectable otherwise. A technique has been developed for toluidine blue staining of the esophagus during panendoscopy. In this initial series of 18 patients with squamous cell carcinoma of the upper aerodigestive tract, we found a 17% incidence of early carcinoma of the esophagus. We believe this technique to be an important adjunct to the evaluation of these patients at high risk for esophageal carcinoma.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 006812546

Download citation: RISBibTeXText

PMID: 2441726

DOI: 10.1001/archotol.1987.01860080070019


Related references

In vivo staining with toluidine blue as an adjunct to the endoscopic detection of Barrett's esophagus. Gastrointestinal Endoscopy 33(2): 99, 1987

Vital staining of squamous cell carcinoma of the conjunctiva using toluidine blue. Acta Ophthalmologica Scandinavica 84(6): 825-826, 2006

Diagnostic modalities for squamous cell carcinoma: an extensive review of literature-considering toluidine blue as a useful adjunct. Journal of Maxillofacial and Oral Surgery 14(2): 188-200, 2015

A pilot study comparing toluidine blue and hematoxylin and eosin staining of basal cell and squamous cell carcinoma during Mohs surgery. Dermatologic Surgery 22(8): 693-697, 1996

Tu1625 Clinical Impact of Screening for Head and Neck Region and Intervention for Early Head and Neck Squamous Cell Carcinoma in Patients With Esophageal Squamous Cell Carcinoma. Gastrointestinal Endoscopy 75(4): Ab468-Ab469, 2012

Cisplatin pharmacokinetics and pharmacodynamics in patients with squamous-cell carcinoma of the head/neck or esophagus. Cancer Chemotherapy & Pharmacology. 39(1-2): 25-33, 1996

Deletion of C9orf53 promotes the growth of head and neck squamous cell carcinoma and is associated with poor prognosis of patients with head and neck squamous cell carcinoma. Oncology Letters 17(1): 1223-1228, 2019

A reason for the use of toluidine blue staining in the presurgical management of patients with oral squamous cell carcinomas. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics 102(6): 741-743, 2006

Toluidine blue staining for detection of oral squamous carcinoma. Nederlands Tijdschrift Voor Tandheelkunde 97(10): 431-432, 1990

Porfiromycin as an adjunct to radiation therapy in squamous cell carcinoma of the head and neck. International Journal of Radiation Oncology Biology Physics 36(1 Suppl. ): 331, 1996

A phase I dose escalation study with anti-CD44v6 bivatuzumab mertansine in patients with incurable squamous cell carcinoma of the head and neck or esophagus. Clinical Cancer Research 12(20 Pt 1): 6064-6072, 2006

A phase I/II study of the hypoxic cell sensitizer misonidazole as an adjunct to high fractional dose radiotherapy in patients with unresectable squamous cell carcinoma of the head and neck: a RTOG randomized study (#79-04). International Journal of Radiation Oncology Biology Physics 16(2): 465-470, 1989

Second-line chemotherapy with bleomycin, methotrexate, and vinorelbine (BMV) for patients with squamous cell carcinoma of the head, neck and esophagus (SCC-HN&E) pretreated with a cisplatin-containing regimen: a phase II study. Journal of ChemoTherapy 15(4): 394-399, 2003

Association of squamous cell carcinoma of the head and neck with cancer of the esophagus. Ajr. American Journal of Roentgenology 131(5): 791-794, 1978

329Pafatinib activity against head-and-neck or esophageal squamous cell carcinoma: Significance of activating oncogenic Her4 mutations in head-and-neck squamous cell carcinoma. Annals of Oncology 26(Suppl 9): ix97.3-ix97, 2015